brivaracetam clinical trials

A Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study With a 2-Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

This study is looking at a medicine called brivaracetam to see how well it works and if it's safe for children and young people (ages 2 to 25) with certain types of epilepsy (Childhood Absence Epilepsy or Juvenile Absence Epilepsy). It's comparing the medicine to a dummy pill (placebo) to see if it reduces seizures.